NeuroPace annual r&d spending
2020
2021
2022
2023
2024
2025
NeuroPace R&D Spending Growth & History (NPCE)
NeuroPace's r&d spending was $27.9M for fiscal 2025.
View full NeuroPace company overviewNeuroPace annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $27.9M | $4.2M | +17.90% |
| 2024 | 2024-12-31 | $23.7M | $2.9M | +13.84% |
| 2023 | 2023-12-31 | $20.8M | −$1.2M | −5.32% |
| 2022 | 2022-12-31 | $21.9M | $3.7M | +20.51% |
| 2021 | 2021-12-31 | $18.2M | $2.5M | +16.03% |
| 2020 | 2020-12-31 | $15.7M | — | — |
NeuroPace quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.9M | $53,000 | +0.77% |
| Q1 2026 | 2026-03-31 | $7.2M | −$251,000 | −3.37% |
| Q4 2025 | 2025-12-31 | $7.0M | $977,000 | +16.15% |
| Q3 2025 | 2025-09-30 | $6.6M | $822,000 | +14.29% |
| Q2 2025 | 2025-06-30 | $6.8M | $780,000 | +12.86% |
| Q1 2025 | 2025-03-31 | $7.4M | $1.7M | +28.63% |
| Q4 2024 | 2024-12-31 | $6.0M | $673,000 | +12.52% |
| Q3 2024 | 2024-09-30 | $5.8M | $959,000 | +20.00% |
| Q2 2024 | 2024-06-30 | $6.1M | $722,000 | +13.51% |
| Q1 2024 | 2024-03-31 | $5.8M | $521,000 | +9.90% |
| Q4 2023 | 2023-12-31 | $5.4M | $288,000 | +5.66% |
| Q3 2023 | 2023-09-30 | $4.8M | −$816,000 | −14.54% |
| Q2 2023 | 2023-06-30 | $5.3M | −$326,000 | −5.75% |
| Q1 2023 | 2023-03-31 | $5.3M | −$314,000 | −5.63% |
| Q4 2022 | 2022-12-31 | $5.1M | −$256,000 | −4.79% |
| Q3 2022 | 2022-09-30 | $5.6M | $1.3M | +29.61% |
| Q2 2022 | 2022-06-30 | $5.7M | $1.2M | +27.77% |
| Q1 2022 | 2022-03-31 | $5.6M | $1.5M | +36.02% |
| Q4 2021 | 2021-12-31 | $5.3M | $1.4M | +36.39% |
| Q3 2021 | 2021-09-30 | $4.3M | $638,000 | +17.29% |
| Q2 2021 | 2021-06-30 | $4.4M | $1.2M | +36.44% |
| Q1 2021 | 2021-03-31 | $4.1M | −$733,000 | −15.17% |
| Q4 2020 | 2020-12-31 | $3.9M | — | — |
| Q3 2020 | 2020-09-30 | $3.7M | — | — |
| Q2 2020 | 2020-06-30 | $3.3M | — | — |
| Q1 2020 | 2020-03-31 | $4.8M | — | — |
NeuroPace r&d spending trends
Over the last five fiscal years, NeuroPace's r&d spending increased from $15.7M to $27.9M, a change of $12.2M. The latest reported quarter, Q2 2026, shows $6.9M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NeuroPace source filings ↗